The President's Commission on White House Fellows announced the 2023-24 cohort of White House fellows, which included New York-based Indian American cancer physician Kamal Menghrajani. Menghrajani, who specializes in treating leukemia patients, has been assigned to the Office of Science and Technology Policy.
Currently an assistant attending physician at the Memorial Sloan Kettering Cancer Center, Menghrajani’s tenure at the institute has involved active contributions to cancer research, with a specific focus on early diagnosis and prevention. In addition, she was instrumental in launching health equity initiatives for marginalized communities in countries as diverse as Nicaragua, Bolivia, and Uganda.
Menghrajani also co-founded startups aimed at addressing unmet needs in cancer treatment and deploying AI technology for swift cancer diagnosis. She was a driving force behind the expansion of Nourish International, a nonprofit that trains future leaders in the fields of international development and social entrepreneurship.
The Indian American completed an M.D. at the University of North Carolina and an M.S. in Biostatistics at Columbia University. She further honed her medical skills at the University of Michigan and as a chief fellow at the Memorial Sloan Kettering Cancer Center.
“I am ecstatic to be a part of an incredible class of 15 compassionate leaders and brilliant thinkers who are driven by an ethos of public service, and to have an opportunity to serve my patients and colleagues in this new role,” Menghrajani said in a LinkedIn post.
Since its inception in 1964, the White House Fellows program has given aspiring young leaders the chance to work alongside some of the nation's most senior public servants. The Fellows get to spend a year collaborating with senior White House staff, Cabinet Secretaries, and other top-ranking administration officials, making the administration better equipped to serve as leaders in their respective communities.
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login